Second Pharmaceutical Company to Reduce Insulin Prices This Month

Second Pharmaceutical Company to Reduce Insulin Prices This Month

BoroPark24 Staff

After Eli Lilly announced a price reduction for some insulin earlier this month, Novo Nordisk has followed suit. 

On Tuesday, Novo Nordisk announced lower U.S. prices of several pre-filled insulin pens and vials by up to 75% for people living with diabetes. 

The Company said it would lower the list price of four legacy insulin brands, including NovoLog® and NovoLog® Mix 70/30 by 75% off the current list price, and Novolin® and Levemir® by 65% off the current list price. Novo Nordisk also announced it would match the list price of select unbranded biologics (pre-filled pens and vials and pre-mix insulins).

Novo Nordisk says that the price changes will only go into effect on January 1, 2024, while Eli Lilly's price cut will go into effect in the fourth quarter of this year (October).

According to their website, Novo Nordisk currently provides co-pay support for some insulin products meaning eligible patients can pay $25-$35 for their insulin in commercial insurance plans.

The press release states, "Novo Nordisk recognizes that some patients find it difficult to pay for healthcare, including insulin. As such, the Company remains committed to reducing the burden of out-of-pocket costs, helping transform the complex pricing system, and fostering better pricing predictability."

photo credit: Flickr

Mayor Eric Adams visits on Purim the Williamsburg home of longtime askan and advisor R' Avrohom Yaakov Friedman
  • Mar 14 2023
  • |
  • 2:27 PM

New Jersey Turnpike Authority to Clarify Pricing Discounts for NYC E-ZPass Customers
  • Mar 14 2023
  • |
  • 1:15 PM

Be in the know

receive BoroPark24’s news & updates on whatsapp

 Start Now